Clinical trial
Placebo-controlled, Randomized, Double-blind Study of Minocycline for Sporadic and Hereditary Cerebral Amyloid Angiopathy
NCT05680389 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Placebo-controlled, Randomized, Double-blind Study of Minocycline for Sporadic and Hereditary Cerebral Amyloid Angiopathy
- Lead sponsor
- Leiden University Medical Center
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 2, 2020
- Completion date
- December 2, 2023
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.